Streetbeat News

Products Services

CLLS

Cellectis announced that the European Commission has granted Orphan Drug Designation to its product candidate UCART22 for the treatment of Acute Lymphoblastic Leukemia. UCART22 is an allogeneic CAR T-cell product targeting CD22, currently in a Phase 1/2 study.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 8:31 pm

ASNS

Actelis Networks, Inc. (NASDAQ:ASNS) has received new orders to supply cyber-hardened networking technology to three U.S. military bases. This follows recent cybersecurity certifications and placement on the Department of Defense Information Network approved products list.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 8:31 pm

INFA

Informatica has announced native SQL ELT support for Snowflake Cortex AI functions, enhancing data integration and analytics capabilities.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 8:25 pm

DDD

3D Systems announced that it is targeting the commercial launch of its direct printing technology for clear aligners by late 2025.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 8:17 pm

AZTA

Azenta has been chosen by the Crohn's & Colitis Foundation to provide sample management services for its IBD CAPTURE and SIRQC clinical registries, focusing on Crohn's disease and ulcerative colitis research.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 8:15 pm

PSNL

Personalis, Inc. (NASDAQ:PSNL) announced that their NeXT Personal test demonstrated exceptional performance in detecting early-stage breast cancer recurrence and monitoring immunotherapy at the ASCO 2024 conference. The test can detect circulating tumor DNA at ultra-sensitive levels, highlighting its clinical importance.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 8:15 pm

BUD

GTBIF

SAM

TLRY

Green Thumb Industries (OTCQX:GTBIF) has proposed a merger with Boston Beer Co. (NYSE:SAM) to gain access to a major U.S. stock exchange. The merger aims to create a powerful entity in the cannabis and beverage industries, focusing on innovative cannabis-infused products. Boston Beer's stock surged over 20% following the news.

Portfolio Pulse from Patricio Liddle

June 04, 2024 | 8:11 pm

COIN

Bitcoin surged past $70,000 amid rising institutional capital inflows, with notable increases in large transaction volumes and daily active addresses. Ethereum and Dogecoin also saw gains. Analysts predict further growth for Bitcoin, with some expecting it to reach $100,000 by the end of 2024.

Portfolio Pulse from Khyathi Dalal

June 04, 2024 | 8:10 pm

AMZN

HCP

HashiCorp has announced a strategic collaboration with Amazon Web Services (AWS) to enhance infrastructure and security lifecycle management. The five-year agreement includes co-innovation and go-to-market collaboration.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 8:10 pm

RPTX

Repare Therapeutics has received FDA Fast Track designation for its drug Lunresertib in combination with Camonsertib for the treatment of platinum-resistant ovarian cancer.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 8:09 pm